blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1747220

EP1747220 - SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON [Right-click to bookmark this link]
Former [2007/05]SUBSTITUTED 1H-PYRROLO 3,2-B, 3,2-C, AND 2,3-C PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON
[2009/12]
StatusNo opposition filed within time limit
Status updated on  19.02.2010
Database last updated on 14.11.2024
Most recent event   Tooltip27.09.2013Lapse of the patent in a contracting state
New state(s): ES, TR		published on 30.10.2013  [2013/44]
Applicant(s)For all designated states
Aventis Pharmaceuticals Inc.
300 Somerset Corporate Boulevard
Bridgewater, New Jersey 08807 / US
[2007/05]
Inventor(s)01 / METZ, William, A.
45 Shannon Road
Bridgewater, NJ 08807 / US
02 / HALLEY, Frank
3 rue de la Mare Adam
F-92310 Chaville / FR
03 / DUTRUC-ROSSET, Gilles
21 Ave du Docteur Arnold Netter
F-75012 Paris / FR
04 / CHOI-SLEDESKI, Yong, Mi
24 Fisher Farm Road
Belle Mead, New Jersey 08502 / US
05 / POLI, Gregory, B.
2054 Pheasant Court
Bethlehem, PA 18015 / US
06 / FINK, David, M.
One Kensington Court
Lebanon, NJ 08833 / US
07 / DOERFLINGER, Gilles
2 avenue du Berry Residence les Millepertuis
Batiment B3 F-91940 Les Ulis / FR
08 / HUANG, Bao-Guo
10 Shields Lane
Bridgewater, NJ 08807 / US
09 / GELORMINI, Ann, Marie
303-4A Gemini Drive
Hillsborough, NJ 08844 / US
10 / GAMBOA, Juan, A.
225 East 7th Street, 3C
New York, NY 10009 / US
11 / GIOVANNI, Andrew
1 Cornfield Terrace
Flemington, NJ 08822 / US
12 / ROEHR, Joachim, E.
16 Crestview Drive
Bernardsville, NJ 07924 / US
13 / TSAY, Joseph, T.
688 Donald Drive North
Bridgewater, NJ 08807 / US
14 / CAMACHO, Fernando
308 Wayne Terrace
Union, NJ 07083 / US
15 / HURST, William, J.
20 Mountain Ridge Drive
Oxford, NJ 07863 / US
16 / HARNISH, Stephen, W.
74 Old Middletown Road
Wharton, NJ 07885 / US
17 / CHIANG, Yulin
24 Vom Eigen Dr.
Convent Station, NJ 07960 / US
 [2007/05]
Representative(s)Bouvet, Philippe
Aventis Pharma S.A.
Direction des Brevets Tri LEO/144
20 Avenue Raymond Aron
92165 Antony Cedex / FR
[N/P]
Former [2008/35]Bouvet, Philippe
Aventis Pharma S.A. Direction des Brevets Tri LEO/144 20 Avenue Raymond Aron
92165 Antony Cedex / FR
Former [2007/05]Bouvet, Philippe
Aventis Pharmaceuticals Inc, 20, Avenue Raymond Aron
92160 Antony / FR
Application number, filing date04812567.801.12.2004
[2007/05]
WO2004US40080
Priority number, dateUS20030528764P11.12.2003         Original published format: US 528764 P
[2007/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005061498
Date:07.07.2005
Language:EN
[2005/27]
Type: A1 Application with search report 
No.:EP1747220
Date:31.01.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 07.07.2005 takes the place of the publication of the European patent application.
[2007/05]
Type: B1 Patent specification 
No.:EP1747220
Date:15.04.2009
Language:EN
[2009/16]
Search report(s)International search report - published on:EP07.07.2005
ClassificationIPC:C07D471/04, A61K31/437
[2007/05]
CPC:
C07D471/04 (EP,KR,US); A61P25/20 (EP); A61P25/24 (EP);
A61P43/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/05]
Extension statesAL08.12.2006
BA08.12.2006
HR08.12.2006
LV08.12.2006
MK08.12.2006
YU08.12.2006
TitleGerman:SUBSTITUIERTE 1H-PYRROLO[3,2-B, 3,2-C UND 2,3-C]PYRIDIN-2-CARBONSÄUREAMIDE UND VERWANDTE ANALOGA ALS INHIBITOREN VON CASEINKINASE-I-EPSILON[2007/05]
English:SUBSTITUTED 1H-PYRROLO[3,2-B, 3,2-C, AND 2,3-C]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON[2009/16]
French:CARBOXAMIDES 1H-PYRROLO[3,2-B, 3,2-C ET 2,3-C]PYRIDINE-2- SUBSTITUES ET LEURS ANALOGUES UTILISES EN TANT QU'INHIBITEURS DE LA CASEINE KINASE I EPSILON[2009/16]
Former [2007/05]SUBSTITUTED 1H-PYRROLO 3,2-B, 3,2-C, AND 2,3-C PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I EPSILON
Former [2007/05]CARBOXAMIDES 1H-PYRROLO 3,2-B, 3,2-C, ET 2,3-C PYRIDINE-2- SUBSTITUES ET LEURS ANALOGUES UTILISES EN TANT QU'INHIBITEURS DE LA CASEINE KINASE I_G(E)
Entry into regional phase08.12.2006National basic fee paid 
08.12.2006Designation fee(s) paid 
08.12.2006Examination fee paid 
Examination procedure28.09.2006Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time
08.12.2006Examination requested  [2007/05]
13.03.2007Despatch of a communication from the examining division (Time limit: M06)
22.08.2007Reply to a communication from the examining division
28.08.2007Despatch of a communication from the examining division (Time limit: M04)
20.12.2007Reply to a communication from the examining division
16.01.2008Despatch of a communication from the examining division (Time limit: M06)
16.07.2008Reply to a communication from the examining division
18.08.2008Communication of intention to grant the patent
29.12.2008Fee for grant paid
29.12.2008Fee for publishing/printing paid
Opposition(s)18.01.2010No opposition filed within time limit [2010/12]
Fees paidRenewal fee
02.01.2007Renewal fee patent year 03
20.12.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
Penalty fee
Penalty fee Rule 85a EPC 1973
08.12.2006AT   M01   Fee paid on   08.12.2006
08.12.2006BE   M01   Fee paid on   08.12.2006
08.12.2006BG   M01   Fee paid on   08.12.2006
08.12.2006CH   M01   Fee paid on   08.12.2006
08.12.2006CY   M01   Fee paid on   08.12.2006
08.12.2006CZ   M01   Fee paid on   08.12.2006
08.12.2006DE   M01   Fee paid on   08.12.2006
08.12.2006DK   M01   Fee paid on   08.12.2006
08.12.2006EE   M01   Fee paid on   08.12.2006
08.12.2006ES   M01   Fee paid on   08.12.2006
08.12.2006FI   M01   Fee paid on   08.12.2006
08.12.2006FR   M01   Fee paid on   08.12.2006
08.12.2006GB   M01   Fee paid on   08.12.2006
08.12.2006GR   M01   Fee paid on   08.12.2006
08.12.2006HU   M01   Fee paid on   08.12.2006
08.12.2006IE   M01   Fee paid on   08.12.2006
08.12.2006IS   M01   Fee paid on   08.12.2006
08.12.2006IT   M01   Fee paid on   08.12.2006
08.12.2006LT   M01   Fee paid on   08.12.2006
08.12.2006LU   M01   Fee paid on   08.12.2006
08.12.2006MC   M01   Fee paid on   08.12.2006
08.12.2006NL   M01   Fee paid on   08.12.2006
08.12.2006PL   M01   Fee paid on   08.12.2006
08.12.2006PT   M01   Fee paid on   08.12.2006
08.12.2006RO   M01   Fee paid on   08.12.2006
08.12.2006SE   M01   Fee paid on   08.12.2006
08.12.2006SI   M01   Fee paid on   08.12.2006
08.12.2006SK   M01   Fee paid on   08.12.2006
08.12.2006TR   M01   Fee paid on   08.12.2006
Penalty fee Rule 85b EPC 1973
08.12.2006M01   Fee paid on   08.12.2006
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipRO15.04.2009
TR15.04.2009
AT01.12.2009
CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
IT01.12.2009
LT01.12.2009
LU01.12.2009
PL01.12.2009
SK01.12.2009
ES02.12.2009
HU02.12.2009
SE02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
IS31.12.2009
LI31.12.2009
DK04.01.2010
[2013/44]
Former [2011/39]RO15.04.2009
AT01.12.2009
CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
IT01.12.2009
LT01.12.2009
LU01.12.2009
PL01.12.2009
SK01.12.2009
HU02.12.2009
SE02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
IS31.12.2009
LI31.12.2009
DK04.01.2010
Former [2011/32]RO15.04.2009
AT01.12.2009
CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
IT01.12.2009
LT01.12.2009
LU01.12.2009
SK01.12.2009
HU02.12.2009
SE02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
IS31.12.2009
LI31.12.2009
DK04.01.2010
Former [2011/21]RO15.04.2009
CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
IT01.12.2009
LT01.12.2009
LU01.12.2009
SK01.12.2009
HU02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
IS31.12.2009
LI31.12.2009
DK04.01.2010
Former [2011/19]RO15.04.2009
CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
IT01.12.2009
LT01.12.2009
SK01.12.2009
HU02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
IS31.12.2009
LI31.12.2009
DK04.01.2010
Former [2011/15]RO15.04.2009
CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
IT01.12.2009
LT01.12.2009
SK01.12.2009
HU02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
LI31.12.2009
DK04.01.2010
Former [2011/11]RO15.04.2009
CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
LT01.12.2009
SK01.12.2009
HU02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
LI31.12.2009
DK04.01.2010
Former [2011/07]CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
LT01.12.2009
SK01.12.2009
HU02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
LI31.12.2009
DK04.01.2010
Former [2010/51]CY01.12.2009
CZ01.12.2009
FI01.12.2009
IE01.12.2009
LT01.12.2009
SK01.12.2009
HU02.12.2009
SI02.12.2009
BE31.12.2009
CH31.12.2009
EE31.12.2009
LI31.12.2009
Former [2010/46]CZ01.12.2009
FI01.12.2009
IE01.12.2009
LT01.12.2009
SI02.12.2009
Former [2010/38]CZ01.12.2009
FI01.12.2009
LT01.12.2009
SI02.12.2009
Former [2010/36]CZ01.12.2009
LT01.12.2009
SI02.12.2009
Cited inInternational search[A]EP0186367  (WARNER LAMBERT CO [US]) [A] 1-44 * abstract *;
 [A]US5527819  (WILLIAMS THERESA M [US], et al) [A] 1-44 * abstract *;
 [A]WO03078435  (UPJOHN CO [US], et al) [A] 1-44* page 38; claim - *;
 [A]WO03080608  (GLAXO GROUP LTD [GB], et al) [A] 1-44 * page 12; claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.